Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Colorectal Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Valganciclovir 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Biopsy 3Bevacizumab 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Nivolumab 2tocilizumab 1pomalidomide 1pembrolizumab 1liposomal doxorubicin 1emvododstat 1efineptakin alfa 1cabozantinib 1Zidovudine 1Sunitinib 1Polymerase Chain Reaction 1Nelfinavir 1Maraviroc 1Lenalidomide 1Ipilimumab 1Immunohistochemistry 1Imatinib Mesylate 1HhAntag691 1Gene Expression Profiling 1Etoposide 1Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1CTLA-4 Antigen 1Antiretroviral Therapy, Highly Active 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Sarcoma, Kaposi × Maraviroc × Clear all
NCT01276236 2021-03-05

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

University of California, San Francisco

Phase 2 Completed
13 enrolled 16 charts
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡